Your session is about to expire
← Back to Search
Medically Tailored Meals + Lifestyle Intervention for HIV and Type 2 Diabetes (FAME-H Trial)
FAME-H Trial Summary
This trial is testing whether a combination of a medically tailored meal and an intensive lifestyle intervention can help adults with food insecurity, HIV, and Type 2 diabetes, compared to those who just receive a medically tailored meal.
FAME-H Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFAME-H Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FAME-H Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have participated in a study about diabetes, nutrition, or weight in the past year.I am 18 years old or older.I have had cancer other than non-melanoma skin cancer, but it was cured or has been in remission for over 5 years.I am considering or have had bariatric surgery within the last 2 years.My kidney function is severely reduced.I do not have a stable place to live or keep food.You don't always have enough food to eat.You weigh too much for your height.I have been diagnosed with HIV.I have been diagnosed with Type 2 Diabetes or am at high risk for it.You can freely choose and control what you eat.I have an illness that defines AIDS.I am either male or female.You have misused drugs or alcohol in the last 6 months.I occasionally use medications that can affect my blood sugar levels.
- Group 1: Medically Tailored Meal (MTM) + Intensive Lifestyle Intervention (ILI)
- Group 2: Standard MTM
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the total enrolment size for this investigation?
"Affirmative. The information hosted on clinicaltrials.gov attests to this research study being open for recruitment. It was first published on October 4th, 2021 and the last revision occurred in August 3rd of 2022; seeking 200 participants from a single centre."
Is enrollment for the trial currently open?
"Affirmative. This clinical trial is actively recruiting as indicated on the data available through clinicaltrials.gov. The study was first listed on October 4th 2021 and underwent its last update on August 3rd 2022, seeking 200 individuals from a single location for participation."
Share this study with friends
Copy Link
Messenger